multiple myeloma

ASCO: Lilly's faith in Kelonia rewarded with ‘nutty’ CAR-T data

Kelonia shared the largest slice of data yet for its in vivo CAR-T, helping to justify the $3.2 billion price tag Lilly recently paid for the biotech.

Darren Incorvaia May 31, 2026 8:00am

ASCO: BMS CELMoD drug doubles PFS in ‘incredibly exciting’ ph. 3

May 29, 2026 8:00am

CellCentric raises $220M to advance myeloma drug

May 6, 2026 7:00am

Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

After buyout, Gilead is laying off Arcellx staff on both coasts

May 5, 2026 3:12pm

multiple myeloma cells blood flow cancer blood cancer

BMS' CELMoD drug improves myeloma PFS in phase 3

Mar 9, 2026 11:08am

Quest launches residual disease blood test for multiple myeloma

Feb 3, 2026 6:15am